May 29, 2026 08:02AM

Apr 22, 2026 08:04AM

Apr 14, 2026 08:04AM

Apr 2, 2026 06:09AM

Feb 25, 2026 07:59AM

Feb 11, 2026 06:59AM

Feb 4, 2026 04:48PM Tempest closes acquisition of dual-targeting CAR-T assets

Jan 22, 2026 06:04AM

Dec 9, 2025 04:54PM

Nov 19, 2025 09:02AM

Nov 5, 2025 04:17PM

Sep 8, 2025 07:01AM

Aug 11, 2025 04:57PM

Jul 28, 2025 07:00AM Biodexa initiates phase 3 trial for FAP treatment eRapa

Jun 30, 2025 08:10AM

Jun 11, 2025 08:01AM

Jun 5, 2025 10:28AM

May 13, 2025 06:22PM

Apr 21, 2025 08:01AM

Apr 10, 2025 06:02AM

Apr 9, 2025 04:30PM Tempest Therapeutics (TPST) Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value

Mar 28, 2025 06:47AM

Mar 13, 2025 08:00AM

Feb 10, 2025 08:00AM

Jan 6, 2025 08:03AM

Nov 13, 2024 09:30AM

Nov 12, 2024 04:22PM

Nov 12, 2024 08:01AM Tempest Therapeutics (TPST) Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy

Oct 14, 2024 10:41AM

Oct 11, 2024 06:39AM

Oct 10, 2024 07:01AM

Aug 21, 2024 08:02AM

Aug 16, 2024 10:53AM

Aug 15, 2024 08:00AM

Jul 19, 2024 04:33PM Tempest Therapeutics (TPST) Files $300M Mixed Shelf

404,938 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All